GLP-1 Agonists May Reduce Risk of Alcohol Use Disorder Hospitalizations

Some glucagon-like peptide-1 receptor (GLP-1) agonists, prescribed for treatment of diabetes or obesity, may outperform traditional medications in reducing alcohol use disorder (AUD)–related hospitalizations, according to a cohort study published in JAMA Psychiatry.

Authors

Publication Details

Journal
JAMA
Published
2024-12-20
DOI
https://doi.org/10.1001/jama.2024.25503
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLP-1 Agonists May Reduce Risk of Alcohol Use Disorder Hospitalizations

Samantha Anderer
JAMA
Diet and metabolism studies
article

GLP-1 Agonists May Reduce Risk of Alcohol Use Disorder Hospitalizations

Samantha Anderer
article en

Abstract

Some glucagon-like peptide-1 receptor (GLP-1) agonists, prescribed for treatment of diabetes or obesity, may outperform traditional medications in reducing alcohol use disorder (AUD)–related hospitalizations, according to a cohort study published in JAMA Psychiatry.

JAMAVol. 333(3)
Good health and well-being
Openalex Percentile: Top 67%
Diet and metabolism studies
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1 Agonists May Reduce Risk of Alcohol Use Disorder Hospitalizations — Samantha Anderer · JAMA (2024) | TGRS Research Map | TGRS